Posted by on Nov 28, 2013 in Prostate cancer | 0 comments

In a nutshell This review examined the safety and efficacy of zoledronic acid (Zometa) and denosumab (Xgeva), two treatments for bone loss related to advanced prostate cancer. Some background Advanced prostate cancer (PC) can be associated with bone damage caused by bone metastases (cancer that has spread to the bones) or by androgen deprivation...

Read More